A deep learning MR-based radiomic nomogram may predict survival for nasopharyngeal carcinoma patients with stage T3N1M0
Nasopharyngeal carcinoma (NPC) has an unbalanced geographical distribution, with the highest incidence reported in Southeast Asia [1]. There were 129,000 new cases of NPC in 2018 [2] and approximately 70% of them were locoregionally advanced at diagnosis [3]. For patients with locoregionally advanced NPC (LANPC), concurrent chemoradiotherapy (CCRT) with or without induction chemotherapy (ICT) is recommended by the National Comprehensive Cancer Networkguidelines [4].
Source: Radiotherapy and Oncology - Category: Radiology Authors: Lian-Zhen Zhong, Xue-Liang Fang, Di Dong, Hao Peng, Meng-Jie Fang, Cheng-Long Huang, Bing-Xi He, Li Lin, Jun Ma, Ling-Long Tang, Jie Tian Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Learning | Men | Nasopharyngeal Cancer | Radiology | Universities & Medical Training